Center News

Harold Weintraub symposium to honor 16 award winners May 2-3

March 20, 2003

Sixteen graduate students from North America and Europe have been selected to receive the 2003 Harold M. Weintraub Graduate Student Award, sponsored by the Basic Sciences Division.

The recipients, all advanced students at or near the completion of their studies in the biological sciences, will participate in a scientific symposium May 2-3 in Pelton Auditorium. None is from Fred Hutchinson.

Nominations were solicited internationally. The winners were selected on the basis of the quality, originality and significance of their work.

The symposium will include scientific presentations by the awardees, as well as poster presentations by Fred Hutchinson graduate students.

Established in 2000, the award honors the late Dr. Harold Weintraub, a founding member of the Basic Sciences Division who in 1995 died from brain cancer at 49. Weintraub identified genes responsible for instructing cells to differentiate, or develop, into specific tissues such as muscle and bone.

"Hal was one of the most outstanding scientists of his generation and one of the most unpretentious," said Dr. Mark Groudine, director of the Basic Sciences Division. "He had the knack of identifying the important questions in biology and designing experimental approaches that were creative, simple and elegant.

"By nurturing colleagues, students and postdocs, and helping all of us become better scientists, Hal was instrumental in establishing the collegial atmosphere at the Hutchinson Center. We believe having a symposium recognizing the achievements of young scientists is a great way to honor Hal and the recipients of this award."

Recipients will receive a certificate, travel expenses and an honorarium from the Weintraub and Groudine Fund, established to foster intellectual exchange through the promotion of programs for graduate students, fellows and visiting scholars.

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.